ASBP
Aspire Biopharma
ASBP
ASBP
21 hedge funds and large institutions have $17.9M invested in Aspire Biopharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$376K | |
| 2 | +$334K | |
| 3 | +$185K | |
| 4 |
QL
Quarry LP
New York
|
+$10.1K |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$5.34K |
Top Sellers
| 1 | -$376K | |
| 2 | -$284K | |
| 3 | -$218K | |
| 4 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$8.38K |
| 5 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$8.36K |